The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
Does Mounjaro Help With Joint Pain?
Mounjaro (tirzepatide) is not prescribed to treat joint pain directly, but weight loss achieved through this prescription injection may help reduce strain on joints and alleviate associated discomfort. If you have excess weight and joint pain, your GP can assess whether Mounjaro might be suitable as part of your weight management plan alongside NHS tier 3 specialist services. This guide explains the connection between weight, joint health, and what the evidence shows about how weight loss medication may indirectly support joint function.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
How Weight Loss Affects Joint Health
Joint pain, particularly in the knees, hips, and lower back, is often linked to excess weight putting pressure on joints. Research shows that for every kilogram of weight lost, pressure on weight-bearing joints can decrease significantly. Mounjaro is not a joint pain medication — it works as a dual GIP and GLP-1 receptor agonist to help regulate appetite and support weight loss. However, the weight loss that may result from this prescription medication could indirectly ease joint strain.
Weight-related joint pain (sometimes called mechanical joint pain) improves when excess weight is reduced through lifestyle changes or medication-assisted approaches. In clinical trials, tirzepatide helped participants lose an average of 15–21% of body weight, which is substantial enough to potentially benefit joint function. This is particularly relevant for people with osteoarthritis, where weight management is a key NHS-recommended treatment strategy alongside physiotherapy and other interventions.
Clinically BackedWeight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
Mounjaro, NHS Eligibility, and Joint Pain
If you have joint pain alongside excess weight, you may be eligible for prescription weight loss treatment through NHS tier 3 specialist weight management services. Your GP can refer you if your BMI is 30 or above, or 27 or above with weight-related health conditions — which may include osteoarthritis or joint-related mobility issues. Mounjaro is available as a once-weekly injection and comes as a pre-filled KwikPen device.
Access via the NHS typically involves waiting lists and regional variation. Some people also access Mounjaro through private prescribing following an online clinical assessment. Whichever route, a licensed prescriber will assess whether tirzepatide is appropriate for your individual health, considering your medical history and current medications. Always discuss joint pain and any concerns with your GP before starting any weight loss medication.
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
Can Mounjaro directly treat arthritis or joint pain?
No. Mounjaro is not licensed or prescribed to treat joint pain or arthritis directly. It is a weight loss medication. However, the weight loss it may help achieve could reduce strain on joints, particularly weight-bearing joints like knees and hips, potentially easing mechanical joint pain associated with excess weight.
How much weight loss is needed to ease joint pain?
Even modest weight loss of 5–10% of body weight can reduce pressure on joints and improve pain and function. In Mounjaro clinical trials, participants lost 15–21% of body weight on average, which is a substantial reduction likely to benefit joint health. Individual results vary.
Am I eligible for Mounjaro on the NHS if I have joint pain?
You may be eligible through NHS tier 3 specialist services if your BMI is 30 or above, or 27 or above with weight-related health conditions. Joint pain or osteoarthritis related to excess weight could count as a qualifying condition. Your GP can refer you and assess your suitability.
Is Mounjaro better than Wegovy for joint pain?
Neither medication is indicated for joint pain specifically. Both may support weight loss, which could indirectly benefit joints. Mounjaro (tirzepatide) is a dual GIP + GLP-1 agonist; Wegovy (semaglutide) is a GLP-1 agonist. Choice between them depends on individual assessment by your prescriber, not on joint pain relief.
What else can I do alongside weight loss medication for joint pain?
NHS guidance recommends combining weight management with physiotherapy, low-impact exercise (swimming, cycling), anti-inflammatory diet choices, and pain management as needed. Your GP or physiotherapist can advise on a tailored approach. Calculate your BMI using our free BMI calculator to see where you stand, and use our GLP-1 weight loss calculator to project potential outcomes with medication support.
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.